Aller au contenu principal
Texte de la bannière


Find out more on articles related to infectious diseases : Bacteria - virus - fungi.

  • Covid-19 model

    A valid animal model of SARS-CoV-2 infection and its complications might shed light on the pathophysiology of the disease and can be used for assessing the efficacy and safety of novel antiviral compounds.

    At Vibiosphen, we reproduced a mouse model of SARS-CoV-2 infection [1] and modified it to better define key post-infection immunological abnormalities. For this purpose, 7-week-old transgenic (K18-hACE2)2Prlmn male mice were intranasally challenged with a lethal dose (200 PFU/mouse) of SARS-CoV-2 (Wuhan strain).

  • Antimicrobial pollution

    In almost 1 / 4 of the sites monitored worldwide, the concentrations of medicine found in rivers exceed  the levels recommended preserving aquatic biodiversity or to prevent antibiotic resistance: that is one of the outcomes of a study performed through the University of York (United Kingdom), in collaboration with 86 studies institutes, including  the National Research Institute for Agriculture, Food and the Environment (Inrae) in France.

  • Bacterial plate

    The silent pandemic threat is now well known in the field of infectious disease, but yet still few new antimicrobials are coming on the market. Even if a recent study showed that in 2019, 1,2 Million death was due to resistant bacterial infections and thus more death was attributed to bacterial infection than HIV or Malaria.

  • Real life phage therapy 

    Antimicrobial resistance (AMR) is often viewed as a concept but not as a reality. Highlighting stories of real-life dramatic patient AMR is essential for sensibilization. 

  • Antimicrobial resistance (AMR)

    Nowadays, we face the Covid-19 pandemics but under our radar the silent pandemic is rising. It is common to hear about the outbreaks of flu, malaria, or outbreaks from new Covid-19 variant. It is less common to heard about the outbreaks of antimicrobial resistance (AMR) referred as the silent pandemic.

  • One health pillars (human health, animal health, environment health)

    The one health concept intends to avoid new pandemics by having a systemic point of view of the situation. We can take the concept as a two pillars solution. On the one hand by controlling the exposition of livestock with wildlife to reduce the cross-contamination and on the other hand by controlling the risk of emerging diseases inside the livestock.

  • ESKAPE pathogens

    The emergence of bacterial pathogens with acquired resistance to almost all available antimicrobials is one of the major concerns today. Resistant pathogens are causing 700,000 deaths per year. It is expected by 2050 that infectious diseases will be responsible for more than 10 million deaths per year, a number higher than the 8.2 million caused by cancer today.

  • Bacteriocin

    Bacteriocins, also known as antimicrobial peptides, are produced naturally by bacteria. Bacteriocins have antimicrobial activity against bacteria closely related to the producer strain in order to protect their ecological niche.

  • Placholder

    Drugs have a significant impact on the gut microbiome, but the opposite is also true, gut microbiome has an impact on how the drug fulfills its mission. The onehealth paradigm is once again highlighted as a potential game-changer for treatment efficacy and toxicity elaboration.